Trial Search Results

Guided Self-Help for Binge Eating Disorder

The proposed study will employ a randomized design to evaluate the efficacy of two group-based guided self-help treatments: Integrative Response Therapy (IRT) and Cognitive Behavior Therapy Guided Self-Help, a treatment of known efficacy, in group-format (CBT-GSHg) in the treatment of Binge Eating Disorder (BED), and explore (1) moderators and mediators of treatment, (2) the relative cost-effectiveness of the two treatments, and (3) between group differences on secondary measures (e.g., eating disorder and general psychopathology).

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Integrative Response Therapy
  • Behavioral: Cognitive Behavioral Therapy

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Meet DSM-IV research criteria for Binge Eating Disorder (although frequency criteria
   will be lessened to that proposed in DSM-V;1 time per week for 3 months).

   - Be male or female between 18 and 75 years.

   - Be available and committed to attend full treatment and follow-up

   - Adequate transportation to the clinic.

   - Be literate in English (this is required for inclusion because sessions will be
   conducted in English and written and visual materials are in English).

   - Have a Primary Health Care Provider.

Exclusion Criteria:

   - Current psychosis or severe depression with suicidal risk; a severity that would
   likely require additional psychotherapeutic or psychopharmacologic treatment or
   interfere with participation in this group therapy or with day to day functioning.
   Depressive disorders not meeting the intensity factor of the exclusion criteria may be
   entered to the study.

   - Current Anorexia or Bulimia Nervosa or purging behaviors over the past six months.

   - Current drug and/or alcohol abuse/dependence.

   - Current medication primarily indicated for its effect on appetite or weight, unless
   the participant is willing to withdraw from such medications under supervision of
   their primary care physician.

   - Current chemotherapy.

   - Current participation in psychotherapy, unless the participant is willing to
   discontinue treatment.

   - Psychotropic medication use, including antidepressants, are acceptable if doses were
   stable for at least 1 month prior to assessment.

   - Pregnant or plans to become pregnant within the next 12 months.

   - BMI greater than 45.

   - Planning to have Bariatric surgery within the next 12 months.

   - No transportation

Ages Eligible for Study

18 Years - 75 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Athena Robinson, PhD
650-736-0943
Not Recruiting